Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 3/20 | 0.50 |
| ▸ | PPARG | P37231 | 2/20 | 0.47 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.46 |
| ▸ | PLAAT3 | P53816 | 1/20 | 0.45 |
| ▸ | PLAAT5 | Q96KN8 | 1/20 | 0.45 |
| ▸ | PLAAT2 | Q9NWW9 | 1/20 | 0.45 |
| ▸ | PLAAT4 | Q9UL19 | 1/20 | 0.45 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.45 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
| ▸ | MMP12 | P39900 | 2/20 | 0.41 |
| ▸ | MMP13 | P45452 | 2/20 | 0.41 |
| ▸ | MMP8 | P22894 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22129627 | 1.00 | FFAR1 (0.50) | FFAR1PPARGTBXAS1PLAAT3PLAAT5 | |
| SCHEMBL22129594 | 0.99 | FFAR1 (0.51) | FFAR1PPARGTBXAS1PLAAT3PLAAT5 | |
| SCHEMBL22129638 | 0.94 | FFAR1 (0.53) | FFAR1PPARGTBXAS1PLAAT3PLAAT5 | |
| SCHEMBL22129617 | 0.89 | FFAR1 (0.55) | FFAR1PPARGPLAAT3PLAAT5PLAAT2 | |
| SCHEMBL22129585 | 0.88 | PPARA (0.51) | FFAR1PPARGTBXAS1 | |
| SCHEMBL6255796 | 0.87 | TBXAS1 (0.52) | TBXAS1 | |
| SCHEMBL1122044 | 0.87 | TBXAS1 (0.52) | TBXAS1 | |
| SCHEMBL343141 | 0.87 | TBXAS1 (0.52) | TBXAS1 | |
| SCHEMBL6467606 | 0.87 | TBXAS1 (0.52) | TBXAS1 | |
| SCHEMBL1122039 | 0.87 | TBXAS1 (0.52) | TBXAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240074945-A1 | CURABLE COMPOSITION FOR DENTAL RESTORATION | KURARAY NORITAKE DENTAL INC. (JP) | 2024-03-07 | — | — | US | disclosed |
| EP-4268797-A1 | CURABLE COMPOSITION FOR DENTAL RESTORATION | Kuraray Noritake Dental Inc. (JP) | 2023-11-01 | — | — | EP | disclosed |
| US-20220218572-A1 | DENTAL RESTORATIVE CURABLE COMPOSITION | KURARAY NORITAKE DENTAL INC. (JP) | 2022-07-14 | — | — | US | disclosed |
| US-11365280-B2 | Photocurable resin composition | KURARAY NORITAKE DENTAL INC. (JP) | 2022-06-21 | — | — | US | disclosed |
| EP-3778681-A1 | PHOTOCURABLE RESIN COMPOSITION | Kuraray Noritake Dental Inc. (JP) | 2021-02-17 | — | — | EP | disclosed |
| US-20210024682-A1 | PHOTOCURABLE RESIN COMPOSITION | KURARAY NORITAKE DENTAL INC. (JP) | 2021-01-28 | — | — | US | disclosed |
| WO-2020129736-A1 | RESIN COMPOSITION FOR OPTICAL MOLDING | クラレノリタケデンタル株式会社 | 2020-06-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11365280-B2 | Photocurable resin composition | MAT1A, MAT2A, MAT2B | FFAR1 335/4885PPARG 2822/4885TBXAS1 2818/4885 |
| US-20210024682-A1 | PHOTOCURABLE RESIN COMPOSITION | MAT1A, MAT2A, MAT2B | FFAR1 335/4885PPARG 2822/4885TBXAS1 2818/4885 |
| US-20240074945-A1 | CURABLE COMPOSITION FOR DENTAL RESTORATION | SMCHD1, WDR26, KAT6A | FFAR1 1296/4885PPARG 3074/4885TBXAS1 4522/4885 |
| US-20220218572-A1 | DENTAL RESTORATIVE CURABLE COMPOSITION | REV1, MMAB, WDR1 | FFAR1 1463/4885PPARG 4199/4885TBXAS1 4217/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.